Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly.

Gras-Miralles B, Cremonini F.

Clin Interv Aging. 2013;8:191-200. doi: 10.2147/CIA.S30729. Review.

2.

Lubiprostone for chronic idiopathic constipation and irritable bowel syndrome with constipation.

Saad R, Chey WD.

Expert Rev Gastroenterol Hepatol. 2008 Aug;2(4):497-508. doi: 10.1586/17474124.2.4.497.

PMID:
19072397
3.

Lubiprostone: chronic constipation and irritable bowel syndrome with constipation.

Lacy BE, Chey WD.

Expert Opin Pharmacother. 2009 Jan;10(1):143-52. doi: 10.1517/14656560802631319 . Review.

PMID:
19236188
4.

Lubiprostone: chloride channel activator for chronic constipation.

Rivkin A, Chagan L.

Clin Ther. 2006 Dec;28(12):2008-21. Review.

PMID:
17296458
5.

Lubiprostone--a novel treatment for irritable bowel syndrome with constipation.

Owen RT.

Drugs Today (Barc). 2008 Sep;44(9):645-52. doi: 10.1358/dot.2008.44.9.1269852. Review.

PMID:
19137119
6.

Lubiprostone: in constipation-predominant irritable bowel syndrome.

Carter NJ, Scott LJ.

Drugs. 2009 Jun 18;69(9):1229-37. doi: 10.2165/00003495-200969090-00007. Review.

PMID:
19537839
7.

Clinical pharmacology of lubiprostone, a chloride channel activator in defecation disorders.

Ginzburg R, Ambizas EM.

Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1091-7. doi: 10.1517/17425255.4.8.1091 . Review.

PMID:
18680443
8.

Lubiprostone for the treatment of opioid-induced bowel dysfunction.

Wong BS, Camilleri M.

Expert Opin Pharmacother. 2011 Apr;12(6):983-90. doi: 10.1517/14656566.2011.566559. Review.

PMID:
21385112
9.

Lubiprostone: RU 0211, SPI 0211.

[No authors listed]

Drugs R D. 2005;6(4):245-8. Review.

PMID:
15991886
10.

Lubiprostone for constipation and irritable bowel syndrome with constipation.

Tuteja AK, Rao SS.

Expert Rev Gastroenterol Hepatol. 2008 Dec;2(6):727-33. doi: 10.1586/17474124.2.6.727.

PMID:
19090733
11.

Lubiprostone: a novel treatment for chronic constipation.

Lacy BE, Levy LC.

Clin Interv Aging. 2008;3(2):357-64. Review.

12.

Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.

Raschi E, De Ponti F.

Expert Opin Drug Metab Toxicol. 2014 Feb;10(2):293-305. doi: 10.1517/17425255.2013.876410. Review.

PMID:
24387275
13.

A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.

Cryer B, Katz S, Vallejo R, Popescu A, Ueno R.

Pain Med. 2014 Nov;15(11):1825-34. doi: 10.1111/pme.12437.

14.

Lubiprostone: a chloride channel activator.

Lacy BE, Levy LC.

J Clin Gastroenterol. 2007 Apr;41(4):345-51. Review.

PMID:
17413599
15.

Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome.

Chamberlain SM, Rao SS.

Expert Opin Drug Saf. 2012 Sep;11(5):841-50. doi: 10.1517/14740338.2012.708732. Review.

PMID:
22834474
16.

A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.

Jamal MM, Adams AB, Jansen JP, Webster LR.

Am J Gastroenterol. 2015 May;110(5):725-32. doi: 10.1038/ajg.2015.106.

17.

Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome.

Schey R, Rao SS.

Dig Dis Sci. 2011 Jun;56(6):1619-25. doi: 10.1007/s10620-011-1702-2. Review.

PMID:
21523369
18.

Lubiprostone: a chloride channel activator for treatment of chronic constipation.

Ambizas EM, Ginzburg R.

Ann Pharmacother. 2007 Jun;41(6):957-64. Review.

PMID:
17519292
19.

[New drugs for the treatment of constipation].

Adam B, Liebregts T, Gerken G.

Med Klin (Munich). 2010 Jul;105(7):475-8. doi: 10.1007/s00063-010-1081-z. Review. German.

PMID:
20676949
20.

Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.

Marciniak CM, Toledo S, Lee J, Jesselson M, Bateman J, Grover B, Tierny J.

World J Gastroenterol. 2014 Nov 21;20(43):16323-33. doi: 10.3748/wjg.v20.i43.16323.

Items per page

Supplemental Content

Support Center